Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia

被引：0
|
作者：
Hiroshi Matsuo
Eiji Ishikawa
Hirofumi Machida
Yasuhide Mizutani
Akiko Tanoue
Takahiro Ohnishi
Tomohiro Murata
Shinya Okamoto
Toru Ogura
Yuki Nishimura
Hiroo Ito
Masashi Yasutomi
Kan Katayama
Shinsuke Nomura
Masaaki Ito
机构：
[1] Suzuka Kaisei Hospital,Department of Kidney Center
[2] Mie University Graduate School of Medicine,Department of Cardiology and Nephrology
[3] Takeuchi Hospital,Department of Internal Medicine
[4] Yokkaichi Hazu Medical Center,Department of Nephrology
[5] Murase Hospital,Department of Internal Medicine
[6] Ise Red Cross Hospital,Department of Nephrology
[7] Mie University Hospital,Clinical Research Support Center
[8] Nabari City Hospital,Department of Internal Medicine
[9] Kuwana City Medical Center,Department of Nephrology
来源：
Clinical and Experimental Nephrology | 2020年 / 24卷
关键词：
Chronic kidney disease; Febuxostat; Hyperuricemia; Topiroxostat; Urinary protein; Xanthine oxidase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 313
页数：6
相关论文
共 50 条
  • [1] Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia
    Matsuo, Hiroshi
    Ishikawa, Eiji
    Machida, Hirofumi
    Mizutani, Yasuhide
    Tanoue, Akiko
    Ohnishi, Takahiro
    Murata, Tomohiro
    Okamoto, Shinya
    Ogura, Toru
    Nishimura, Yuki
    Ito, Hiroo
    Yasutomi, Masashi
    Katayama, Kan
    Nomura, Shinsuke
    Ito, Masaaki
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (04) : 307 - 313
  • [2] Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia
    Eleftheriadis, Theodoros
    Pissas, Georgios
    Liakopoulos, Vassilios
    Stefanidis, Ioannis
    [J]. KIDNEY INTERNATIONAL, 2018, 94 (04) : 830 - 831
  • [3] HYPERURICEMIA IN NEOPLASTIC DISEASE IN CHILDREN - PREVENTION WITH ALLOPURINOL A XANTHINE OXIDASE INHIBITOR
    KRAKOFF, IH
    MURPHY, ML
    [J]. PEDIATRICS, 1968, 41 (1P1) : 52 - &
  • [4] Efficacy and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase for the Treatment of Hyperuricemia in Kidney Transplant Recipients
    Tojimbara, T.
    Nakajima, I.
    Yashima, J.
    Fuchinoue, S.
    Teraoka, S.
    [J]. TRANSPLANTATION PROCEEDINGS, 2014, 46 (02) : 511 - 513
  • [5] Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia Reply
    Panchapakesan, Usha
    Pollock, Carol
    [J]. KIDNEY INTERNATIONAL, 2018, 94 (04) : 831 - 831
  • [6] Xanthine oxidase activation in chronic heart failure patients with concomitant chronic kidney disease
    Kolomiiets, M.
    Bilchenko, A.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 988 - 988
  • [7] Febuxostat: A selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout
    Bruce, Susan P.
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (12) : 2187 - 2194
  • [8] Hyperuricemia Resistant to a Xanthine Oxidase Inhibitor, Topiroxostat: a Case Report
    Takahide Kimura
    Seiki Yamada
    Masayuki Tanemoto
    [J]. SN Comprehensive Clinical Medicine, 4 (1)
  • [9] EFFECTS OF A XANTHINE OXIDASE INHIBITOR ON THIOPURINE METABOLISM, HYPERURICEMIA AND GOUT
    RUNDLES, RW
    WYNGAARDEN, JB
    HITCHINGS, GH
    ELION, GB
    SILBERMAN, HR
    [J]. TRANSACTIONS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1963, 76 : 126 - 140
  • [10] Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor
    Foody, JoAnne
    Turpin, Robin S.
    Tidwell, Beni A.
    Lawrence, Debra
    Schulman, Kathy L.
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (08): : 393 - 400
12345